Core Viewpoint - Encompass Health Corporation reported strong financial results for Q4 2024, with significant growth in net operating revenue and adjusted EBITDA, driven by increased discharges and operational capacity expansion [2][3][12]. Financial Performance - Net operating revenue for Q4 2024 was 1,246.8 million in Q4 2023, representing a growth of 12.7% [2][12]. - Income from continuing operations attributable to Encompass Health per diluted share increased to 0.94 in the previous year [2][12]. - Adjusted earnings per share rose to 0.95 [2][12]. - Cash flows from operating activities increased by 38.7% to 201.0 million in Q4 2023 [2][12]. - Adjusted EBITDA for Q4 2024 was 255.0 million in Q4 2023 [2][12]. Operational Highlights - The company reported 63,839 discharges in Q4 2024, a 7.8% increase from 59,247 in Q4 2023, with same-store discharge growth of 5.8% [2][12]. - Net patient revenue per discharge increased by 4.2%, reaching 20,538 in the previous year [2][12]. - For the full year 2024, net operating revenue grew by 11.9% and adjusted EBITDA increased by 13.7% [3]. Capacity Expansion - In 2024, Encompass Health expanded its capacity by adding 427 beds through new hospitals and bed additions to existing facilities [3]. 2025 Guidance - The company provided guidance for 2025, projecting net operating revenue between 5,900 million, and adjusted EBITDA between 1,200 million [5]. - Adjusted earnings per share from continuing operations are expected to be in the range of 4.96 [5]. Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 166 hospitals across 38 states and Puerto Rico [8]. - The company is recognized for providing high-quality rehabilitative care and has received accolades from Fortune and Forbes [8].
Encompass Health reports results for fourth quarter 2024 and issues 2025 guidance